Company intelligence / Profile preview
Kodikaz Therapeutic Solutions
- Ownership
- Private
- Development stage
- Preclinical
Overview
Kodikaz is developing a proprietary Zip-Code™ Technology platform that enables targeted, efficient, and flexible delivery of gene therapies to specific cell types without using viral vectors. The company is conducting research trials in multiple oncology indications and aims to overcome the limitations of conventional gene therapy approaches by improving specificity and reducing immune responses. Clinical results are not yet published; programs appear to be in preclinical or early clinical stages[1][3][7][8].
- Therapeutic areas
- OncologyNeurology
- Modalities
- Gene therapies (non-viral delivery)Cell-specific delivery systems[1][8]
- Industry
- Biotech
Drug pipeline
4 assets3 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Kodikaz Therapeutic Solutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Kodikaz Therapeutic Solutions.